Page last updated: 2024-10-31

moclobemide and Aura

moclobemide has been researched along with Aura in 2 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
" In this study, we examined the effect of both acute and chronic treatment with moclobemide on seizures and the action of first-generation antiepileptic drugs: valproate, carbamazepine, phenobarbital and phenytoin."4.02Acute and chronic treatment with moclobemide, a reversible MAO-inhibitor, potentiates the antielectroshock activity of conventional antiepileptic drugs in mice. ( Banach, M; Borowicz-Reutt, KK, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Borowicz-Reutt, KK1
Banach, M1
Hale, AS1

Reviews

1 review available for moclobemide and Aura

ArticleYear
New antidepressants: use in high-risk patients.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Age Factors; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Drug Interactions; Epilep

1993

Other Studies

1 other study available for moclobemide and Aura

ArticleYear
Acute and chronic treatment with moclobemide, a reversible MAO-inhibitor, potentiates the antielectroshock activity of conventional antiepileptic drugs in mice.
    Pharmacology, biochemistry, and behavior, 2021, Volume: 201

    Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Disease Models, Animal; Dose-Response Relationship,

2021